NYSEAMERICAN:CVRS - Corindus Vascular Robotics Stock Price, Forecast & News

Corindus Vascular Robotics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CVRS."

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) issued its quarterly earnings results on Tuesday, August, 7th. The medical equipment provider reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.01. The medical equipment provider earned $1.67 million during the quarter, compared to analyst estimates of $3 million. View Corindus Vascular Robotics' Earnings History.

1 equities research analysts have issued 1 year price objectives for Corindus Vascular Robotics' shares. Their forecasts range from $4.28 to $4.28. On average, they anticipate Corindus Vascular Robotics' stock price to reach $4.28 in the next twelve months. This suggests a possible upside of 0.2% from the stock's current price. View Analyst Price Targets for Corindus Vascular Robotics.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Corindus Vascular Robotics in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Corindus Vascular Robotics.

Media headlines about CVRS stock have trended somewhat positive this week, according to InfoTrie Sentiment. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Corindus Vascular Robotics earned a coverage optimism score of 2.0 on InfoTrie's scale. They also assigned media coverage about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Corindus Vascular Robotics.

Some companies that are related to Corindus Vascular Robotics include Consort Medical (CSRT), Ekf Diagnostics (EKF), Immunodiagnostic Systems (IDH), Theralase Technologies (TLT), Intelligent Ultrasound Group (MED), LiDCO Group (LID), Deltex Medical Group (DEMG), InspireMD (NSPR), Zecotek Photonics (ZMS), Lucid (LCDX), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Corindus Vascular Robotics investors own include Amarin (AMRN), TransEnterix (TRXC), Micron Technology (MU), Advanced Micro Devices (AMD), Alibaba Group (BABA), Helios and Matheson Analytics (HMNY), TherapeuticsMD (TXMD), Anavex Life Sciences (AVXL), Exelixis (EXEL) and NVIDIA (NVDA).

Shares of CVRS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVRS stock can currently be purchased for approximately $4.27.

Corindus Vascular Robotics has a market capitalization of $891.08 million. Corindus Vascular Robotics employs 90 workers across the globe.View Additional Information About Corindus Vascular Robotics.

The official website for Corindus Vascular Robotics is http://www.corindus.com/.

Corindus Vascular Robotics' mailing address is 309 Waverley Oaks Rd Ste 105, WALTHAM, MA 02452-8451, United States. The medical equipment provider can be reached via phone at +1-508-6533335.